Clinical Genomics, a leading provider of liquid biopsy cancer testing solutions, today announced the Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to Clinical Genomics Pathology Inc., based on results...
Read More »Exosome Diagnostics Announces Launch of ExoDx® Prostate(IntelliScore), a Completely Non-Invasive Liquid Biopsy Test
World’s First and Only Test Analyzing Genetic Information from Exosomes Via a Simple Urine Collection Requiring No Digital Rectal Exam Potential to Avoid Over One Million Unnecessary Prostate Biopsies Each Year Worldwide Exosome Diagnostics, Inc. announced the launch of its ...
Read More »Norgen Biotek Corp Announces Supply Agreement with Biodesix Enabling the First EML4-ALK Liquid Biopsy Test with Results in 72-Hours
THOROLD, ON, March 2, 2016 /CNW/ – Norgen Biotek Corp., an innovative Canadian biotechnology company focusing on advancing powerful tools for DNA, RNA and protein stabilization and purification, today announced the signing of a supplier agreement with Biodesix, Inc. to ...
Read More »Transgenomic Launches New MX-ICP Panels for Liquid Biopsy Detection of RAS and PIK3CA Tumor Mutations
Now Has Six Liquid Biopsy CLIA Cancer Panels that Leverage Exceptional Sensitivity of Multiplexed ICE COLD-PCR to Detect Actionable Mutations in RAS and PIK3CA Genes Relevant to Treatment of Lung and Colorectal Cancers OMAHA, Neb.–(BUSINESS WIRE)–Transgenomic, Inc. (NASDAQ: TBIO) today ...
Read More »Pairing Finger Stick Samples With NGS, Circulogene Joins Liquid Biopsy Field’s Growing Ranks
from GenomeWeb by Molika Ashford NEW YORK (GenomeWeb) – Hot on the heels of several other new liquid biopsy companies, Circulogene — a new firm offering NGS detection of cancer mutations using finger stick-volume blood samples — announced recently that ...
Read More »Exosome Diagnostics Launches CLIA-Certified Laboratory
Company centralizing U.S. operations ahead of cancer liquid biopsy test launches in 2015 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exosome Diagnostics, Inc., a developer of revolutionary, biofluid-based molecular diagnostics, today announced that it has opened a Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory in Cambridge, ...
Read More »